JAKi safety review: uncertainty requires ongoing vigilance
Thelimbic,
Balancing the cardiovascular and cancer risks of JAK inhibitors against their effectiveness in conditions such as IBD will…
Balancing the cardiovascular and cancer risks of JAK inhibitors against their effectiveness in conditions such as IBD will…
Dr David Liew Balancing the cardiovascular and cancer risks of JAK inhibitors against their effectiveness in conditions such as…